Salvage Radioimmunotherapy of Advanced Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen: Efficacy and Safety in Routine Practice

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.


from Mary Ann Liebert, Inc. publishers via xlomafota13 on Inoreader https://ift.tt/2KNO3Of
via IFTTT